Prevalence of asthmatic smokers: Turkish experience (PASTE Study)

Basit Öğe Kaydı
dc.contributor.authorYildiz F.
dc.contributor.authorDursun A.B.
dc.contributor.authorDisçi R.
dc.contributor.authorAbadoglu O.
dc.contributor.authorAtalay F.
dc.contributor.authorAtes G.
dc.contributor.authorOzge C.
dc.date.accessioned2020-06-25T15:17:32Z
dc.date.available2020-06-25T15:17:32Z
dc.date.issued2014
dc.departmentKırıkkale Üniversitesi
dc.description.abstractBackground: Although both asthma and smoking are major health problems worldwide, smokers are often excluded from asthma studies. Objectives: It was aimed to verify the prevalence of asthmatic smokers in Turkey and assess the effects of smoking based on clinical parameters, exacerbations and hospitalizations because of lack of national data about the prevalence of smoking among asthmatics. Methods: The study protocol was comprised of a retrospective questionnaire. The asthmatic patients were followed in the outpatient clinics of 18 tertiary hospitals selected from seven different geographical regions in Turkey. We evaluated demographic data, smoking habits, asthma-related diseases, respiratory function and emergency visits. Results: The study population included 1385 patients (M/F: 343/1042), and the mean age was 45.1±14.0 years. Current and former smoking prevalence was 11.4% and 15.1%, respectively. Smoker rates were higher in males and younger asthmatics compared with females and older asthmatics (P<0.01 and P<0.05, respectively). Smoking history ranged from 0.20 to 90 pack-years (the mean was 12.9), and smokers had a higher level of education compared with nonsmokers (P<0.01). Socioeconomically, the most developed region had the highest rate of smoker asthmatics (33.9%; P=0.014). There was an increase in the number of exacerbations in smoker asthmatics during the previous year, but it was not statistically significant (P>0.05). Conclusion: We showed that the smoking prevalence in Turkey was lower in asthmatics (11.4%) compared with the general population (44.5%). Nevertheless, every effort should be made to encourage asthmatics to stop smoking because smoking is a modifiable risk factor for adverse asthma health outcomes. © 2013 John Wiley and Sons Ltd.en_US
dc.identifier.doi10.1111/crj.12079
dc.identifier.endpage356en_US
dc.identifier.issn17526981
dc.identifier.issue3en_US
dc.identifier.pmid24279873
dc.identifier.scopus2-s2.0-84903816143
dc.identifier.scopusqualityQ3
dc.identifier.startpage350en_US
dc.identifier.urihttps://doi.org/10.1111/crj.12079
dc.identifier.urihttps://hdl.handle.net/20.500.12587/2417
dc.identifier.volume8en_US
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherBlackwell Publishing Ltden_US
dc.relation.ispartofClinical Respiratory Journal
dc.relation.publicationcategoryMakale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAsthmaen_US
dc.subjectAsthma controlen_US
dc.subjectExacerbationen_US
dc.subjectPrevalenceen_US
dc.subjectSmokingen_US
dc.subjectSpirometryen_US
dc.subjectTurkeyen_US
dc.titlePrevalence of asthmatic smokers: Turkish experience (PASTE Study)en_US
dc.typeArticle

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu